Merck Tbk PT operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck Tbk PT with three other
pharmaceutical manufacturers in Asia:
Qianjiang Yongan Pharmaceutical Co Ltd
sales of 555.85 million Chinese Renmimbi [US$82.49 million]
of which 73%
was Medical Manufacturing),
Ttk Healthcare Limited
(4.83 billion Indian Rupees [US$72.44 million]
of which 54%
was Pharmaceuticals), and
Samil Pharmaceutical Co., Ltd.
based in South Korea
(88.14 billion Korean Won [US$78.71 million]
Merck Tbk PT reported sales of 983.45 billion Indonesian Rupiahs (US$75.63 million)
December of 2015.
increase of 13.9%
versus 2014, when the company's sales were 863.21 billion Indonesian Rupiahs.
Despite this increase, sales are still
below the level achieved in 2013, when Merck Tbk PT
reported sales of 1.19 trillion Indonesian Rupiahs.
Sales of Consumer Healthcare saw an increase
17.2% in 2015, from
388.16 billion Indonesian Rupiahs to 455.11 billion Indonesian Rupiahs.